Transforming Part D Changes into Opportunities for Member Value
CMS’s Contract Year 2026 Final Rule is prompting health plans to rethink their approach to Medication Therapy Management (MTM). With CMR completion still a display measure and incentives in flux, the focus is shifting from checking boxes to delivering measurable value. Forward-looking plans are seizing this moment to redesign MTM strategies that boost quality performance, elevate member experience, and drive stronger ROI.
Join us to discover how your organization can:
- Navigate CMS changes and align MTM strategies with new regulatory expectations
- Go beyond CMR completion to demonstrate true value and ROI
- Leverage pharmacist-led outreach to improve adherence and member outcomes
- Advance health equity through tech-enabled, multilingual engagement
- Incorporate AI to support RN case managers and pharmacists, reduce operational headwinds, and enhance quality assurance through data-driven insights
- Incorporate AI to reduce operational headwinds, and improve quality assurance
Whether you’re pursuing 5-Star performance or guiding strategy in growing Medicaid markets, join us to turn regulatory change into meaningful opportunity.
